Literature DB >> 34432866

Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathway.

Katie Lee1,2, Mark G Evans3, Lei Yang4, Spencer Ng1, Caroline Snowden1,2, Michael Khodadoust5,1, Ryanne A Brown1,6, Nicholas A Trum7, Christiane Querfeld7, Linda T Doan8, Jinming Song9, Hailing Zhang9, Alejandro A Gru10, Gary S Wood11, David A Wada1,12, Vignesh Shanmugam3, Paul L Haun13, Jon C Aster3, Lyn M Duncan14, Joan Guitart1, David M Weinstock4, Valentina Nardi14, Jaehyuk Choi1,2,15,16.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34432866      PMCID: PMC8662071          DOI: 10.1182/blood.2021012536

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   25.476


× No keyword cloud information.
  18 in total

1.  Allosteric inhibitors of Bcr-abl-dependent cell proliferation.

Authors:  Francisco J Adrián; Qiang Ding; Taebo Sim; Anastasia Velentza; Christine Sloan; Yi Liu; Guobao Zhang; Wooyoung Hur; Sheng Ding; Paul Manley; Jürgen Mestan; Doriano Fabbro; Nathanael S Gray
Journal:  Nat Chem Biol       Date:  2006-01-15       Impact factor: 15.040

2.  Anchored multiplex PCR for targeted next-generation sequencing.

Authors:  Zongli Zheng; Matthew Liebers; Boryana Zhelyazkova; Yi Cao; Divya Panditi; Kerry D Lynch; Juxiang Chen; Hayley E Robinson; Hyo Sup Shim; Juliann Chmielecki; William Pao; Jeffrey A Engelman; A John Iafrate; Long Phi Le
Journal:  Nat Med       Date:  2014-11-10       Impact factor: 53.440

3.  Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E).

Authors:  Joonhee Park; Jingyi Yang; Alexander T Wenzel; Akshaya Ramachandran; Wung J Lee; Jay C Daniels; Juhyun Kim; Estela Martinez-Escala; Nduka Amankulor; Barbara Pro; Joan Guitart; Marc L Mendillo; Jeffrey N Savas; Titus J Boggon; Jaehyuk Choi
Journal:  Blood       Date:  2017-07-10       Impact factor: 22.113

Review 4.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

5.  Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas.

Authors:  Joan Guitart; M Estela Martinez-Escala; Antonio Subtil; Madeleine Duvic; Melissa P Pulitzer; Elise A Olsen; Ellen Kim; Alain H Rook; Sara S Samimi; Gary S Wood; Michael Girardi; Jacqueline Junkins-Hopkins; Doina S Ivan; M Angelica Selim; Kimberly A Sable; Pooja Virmani; Laura B Pincus; Michael T Tetzlaff; Jinah Kim; Youn H Kim
Journal:  Mod Pathol       Date:  2017-01-27       Impact factor: 7.842

6.  Recurrent STAT3-JAK2 fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract.

Authors:  Ayush Sharma; Naoki Oishi; Rebecca L Boddicker; Guangzhen Hu; Hailey K Benson; Rhett P Ketterling; Patricia T Greipp; Darlene L Knutson; Sara M Kloft-Nelson; Rong He; Bruce W Eckloff; Jin Jen; Asha A Nair; Jaime I Davila; Surendra Dasari; Konstantinos N Lazaridis; N Nora Bennani; Tsung-Teh Wu; Grzegorz S Nowakowski; Joseph A Murray; Andrew L Feldman
Journal:  Blood       Date:  2018-03-28       Impact factor: 25.476

7.  Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods.

Authors:  Brian J Haas; Alexander Dobin; Bo Li; Nicolas Stransky; Nathalie Pochet; Aviv Regev
Journal:  Genome Biol       Date:  2019-10-21       Impact factor: 13.583

8.  Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneity.

Authors:  Joonhee Park; Jay Daniels; Tim Wartewig; Kimberly G Ringbloom; Maria Estela Martinez-Escala; Sara Choi; Jane J Thomas; Peter G Doukas; Jingyi Yang; Caroline Snowden; Calvin Law; Yujin Lee; Katie Lee; Yancong Zhang; Carly Conran; Kyle Tegtmeyer; Samuel H Mo; David R Pease; Balaji Jothishankar; Pui-Yan Kwok; Farah R Abdulla; Barbara Pro; Abner Louissaint; Titus J Boggon; Jeffrey Sosman; Joan Guitart; Deepak Rao; Jürgen Ruland; Jaehyuk Choi
Journal:  Blood       Date:  2021-10-07       Impact factor: 25.476

9.  Piloting a Deep Learning Model for Predicting Nuclear BAP1 Immunohistochemical Expression of Uveal Melanoma from Hematoxylin-and-Eosin Sections.

Authors:  Hongrun Zhang; Helen Kalirai; Amelia Acha-Sagredo; Xiaoyun Yang; Yalin Zheng; Sarah E Coupland
Journal:  Transl Vis Sci Technol       Date:  2020-09-01       Impact factor: 3.283

Review 10.  Deep learning in cancer pathology: a new generation of clinical biomarkers.

Authors:  Amelie Echle; Niklas Timon Rindtorff; Titus Josef Brinker; Tom Luedde; Alexander Thomas Pearson; Jakob Nikolas Kather
Journal:  Br J Cancer       Date:  2020-11-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.